Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Nucleation capacity and presence of centrioles define a distinct category of centrosome abnormalities that induces multipolar mitoses in cancer cells.

Difilippantonio MJ, Ghadimi BM, Howard T, Camps J, Nguyen QT, Ferris DK, Sackett DL, Ried T.

Environ Mol Mutagen. 2009 Oct;50(8):672-96. doi: 10.1002/em.20532.

2.

Polo-like kinase 1-mediated phosphorylation of the GTP-binding protein Ran is important for bipolar spindle formation.

Feng Y, Yuan JH, Maloid SC, Fisher R, Copeland TD, Longo DL, Conrads TP, Veenstra TD, Ferris A, Hughes S, Dimitrov DS, Ferris DK.

Biochem Biophys Res Commun. 2006 Oct 13;349(1):144-52. Epub 2006 Aug 14.

PMID:
16930555
3.

Wortmannin, a widely used phosphoinositide 3-kinase inhibitor, also potently inhibits mammalian polo-like kinase.

Liu Y, Shreder KR, Gai W, Corral S, Ferris DK, Rosenblum JS.

Chem Biol. 2005 Jan;12(1):99-107.

4.

Polo-like kinase 1 inactivation following mitotic DNA damaging treatments is independent of ataxia telangiectasia mutated kinase.

Yuan JH, Feng Y, Fisher RH, Maloid S, Longo DL, Ferris DK.

Mol Cancer Res. 2004 Jul;2(7):417-26.

5.

Trophic factor withdrawal: p38 mitogen-activated protein kinase activates NHE1, which induces intracellular alkalinization.

Khaled AR, Moor AN, Li A, Kim K, Ferris DK, Muegge K, Fisher RJ, Fliegel L, Durum SK.

Mol Cell Biol. 2001 Nov;21(22):7545-57.

6.

Polo-like kinase is required for the fragmentation of pericentriolar Golgi stacks during mitosis.

Sütterlin C, Lin CY, Feng Y, Ferris DK, Erikson RL, Malhotra V.

Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9128-32. Epub 2001 Jul 10.

7.

Polo-like kinase interacts with proteasomes and regulates their activity.

Feng Y, Longo DL, Ferris DK.

Cell Growth Differ. 2001 Jan;12(1):29-37.

8.

Neuronal polo-like kinase in Alzheimer disease indicates cell cycle changes.

Harris PL, Zhu X, Pamies C, Rottkamp CA, Ghanbari HA, McShea A, Feng Y, Ferris DK, Smith MA.

Neurobiol Aging. 2000 Nov-Dec;21(6):837-41.

PMID:
11124427
9.

Caenorhabditis elegans contains a third polo-like kinase gene.

Chase D, Golden A, Heidecker G, Ferris DK.

DNA Seq. 2000;11(3-4):327-34.

PMID:
11092748
10.

The polo-like kinase PLK-1 is required for nuclear envelope breakdown and the completion of meiosis in Caenorhabditis elegans.

Chase D, Serafinas C, Ashcroft N, Kosinski M, Longo D, Ferris DK, Golden A.

Genesis. 2000 Jan;26(1):26-41.

PMID:
10660671
11.

Inhibition of human breast carcinoma growth by a soluble recombinant human CD40 ligand.

Hirano A, Longo DL, Taub DD, Ferris DK, Young LS, Eliopoulos AG, Agathanggelou A, Cullen N, Macartney J, Fanslow WC, Murphy WJ.

Blood. 1999 May 1;93(9):2999-3007.

PMID:
10216096
12.

Association of polo-like kinase with alpha-, beta- and gamma-tubulins in a stable complex.

Feng Y, Hodge DR, Palmieri G, Chase DL, Longo DL, Ferris DK.

Biochem J. 1999 Apr 15;339 ( Pt 2):435-42.

13.

Ubiquitination and proteasome mediated degradation of polo-like kinase.

Ferris DK, Maloid SC, Li CC.

Biochem Biophys Res Commun. 1998 Nov 18;252(2):340-4.

PMID:
9826531
14.

Expression and phosphorylation of fibroblast-growth-factor-inducible kinase (Fnk) during cell-cycle progression.

Chase D, Feng Y, Hanshew B, Winkles JA, Longo DL, Ferris DK.

Biochem J. 1998 Aug 1;333 ( Pt 3):655-60.

15.

Characterization of human N8 protein.

Chen SL, Zhang XK, Halverson DO, Byeon MK, Schweinfest CW, Ferris DK, Bhat NK.

Oncogene. 1997 Nov 20;15(21):2577-88.

16.

IL-7 activates alpha4beta1 integrin in murine thymocytes.

Kitazawa H, Muegge K, Badolato R, Wang JM, Fogler WE, Ferris DK, Lee CK, Candéias S, Smith MR, Oppenheim JJ, Durum SK.

J Immunol. 1997 Sep 1;159(5):2259-64.

PMID:
9278314
17.

Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinase.

Smith MR, Wilson ML, Hamanaka R, Chase D, Kung H, Longo DL, Ferris DK.

Biochem Biophys Res Commun. 1997 May 19;234(2):397-405.

PMID:
9177283
18.

Cell cycle regulation of the human polo-like kinase (PLK) promoter.

Uchiumi T, Longo DL, Ferris DK.

J Biol Chem. 1997 Apr 4;272(14):9166-74.

19.

JAK2 is associated with the c-kit proto-oncogene product and is phosphorylated in response to stem cell factor.

Weiler SR, Mou S, DeBerry CS, Keller JR, Ruscetti FW, Ferris DK, Longo DL, Linnekin D.

Blood. 1996 May 1;87(9):3688-93.

PMID:
8611693
20.

Cell cycle-specific behavior of erythropoietin.

Spivak JL, Ferris DK, Fisher J, Noga SJ, Isaacs M, Connor E, Hankins WD.

Exp Hematol. 1996 Feb;24(2):141-50.

PMID:
8641335
21.

JAK2 is constitutively associated with c-Kit and is phosphorylated in response to stem cell factor.

Linnekin D, Weiler SR, Mou S, DeBerry CS, Keller JR, Ruscetti FW, Ferris DK, Longo DL.

Acta Haematol. 1996;95(3-4):224-8.

PMID:
8677747
22.

In vivo antitumor effects of unconjugated CD30 monoclonal antibodies on human anaplastic large-cell lymphoma xenografts.

Tian ZG, Longo DL, Funakoshi S, Asai O, Ferris DK, Widmer M, Murphy WJ.

Cancer Res. 1995 Nov 15;55(22):5335-41.

23.

Nuclear localization of v-Abl leads to complex formation with cyclic AMP response element (CRE)-binding protein and transactivation through CRE motifs.

Birchenall-Roberts MC, Ruscetti FW, Kasper JJ, Bertolette DC 3rd, Yoo YD, Bang OS, Roberts MS, Turley JM, Ferris DK, Kim SJ.

Mol Cell Biol. 1995 Nov;15(11):6088-99.

24.

Polo-like kinase is a cell cycle-regulated kinase activated during mitosis.

Hamanaka R, Smith MR, O'Connor PM, Maloid S, Mihalic K, Spivak JL, Longo DL, Ferris DK.

J Biol Chem. 1995 Sep 8;270(36):21086-91.

25.

Phosphorylation of a Fes-related protein in response to granulocyte-macrophage colony stimulating factor.

Linnekin D, Mou SM, Greer P, Longo DL, Ferris DK.

J Biol Chem. 1995 Mar 3;270(9):4950-4.

26.

Stem cell factor induces phosphorylation of a 200 kDa protein which associates with c-kit.

Linnekin D, Keller JR, Ferris DK, Mou SM, Broudy V, Longo DL.

Growth Factors. 1995;12(1):57-67.

PMID:
8527164
27.

NF-kappa B/Rel family members are physically associated phosphoproteins.

Li CC, Korner M, Ferris DK, Chen E, Dai RM, Longo DL.

Biochem J. 1994 Oct 15;303 ( Pt 2):499-506.

28.

Staurosporine restores signaling and inhibits interleukin-8-induced chemotactic desensitization.

Johnston JA, Ferris DK, Wang JM, Longo DL, Oppenheim JJ, Kelvin DJ.

Eur J Immunol. 1994 Oct;24(10):2556-62.

PMID:
7925583
29.

Role of the cdc25C phosphatase in G2 arrest induced by nitrogen mustard.

O'Connor PM, Ferris DK, Hoffmann I, Jackman J, Draetta G, Kohn KW.

Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9480-4.

30.

Induction of T cell differentiation and lymphomagenesis in the thymus of mice with severe combined immune deficiency (SCID).

Murphy WJ, Durum SK, Anver MR, Ferris DK, McVicar DW, O'Shea JJ, Ruscetti SK, Smith MR, Young HA, Longo DL.

J Immunol. 1994 Aug 1;153(3):1004-14.

PMID:
7913108
31.
32.

Cloning and characterization of human and murine homologues of the Drosophila polo serine-threonine kinase.

Hamanaka R, Maloid S, Smith MR, O'Connell CD, Longo DL, Ferris DK.

Cell Growth Differ. 1994 Mar;5(3):249-57.

33.

G2 delay induced by nitrogen mustard in human cells affects cyclin A/cdk2 and cyclin B1/cdc2-kinase complexes differently.

O'Connor PM, Ferris DK, Pagano M, Draetta G, Pines J, Hunter T, Longo DL, Kohn KW.

J Biol Chem. 1993 Apr 15;268(11):8298-308.

34.

pp39mos is associated with p34cdc2 kinase in c-mosxe-transformed NIH 3T3 cells.

Zhou R, Daar I, Ferris DK, White G, Paules RS, Vande Woude G.

Mol Cell Biol. 1992 Aug;12(8):3583-9.

35.

Relationships between cdc2 kinase, DNA cross-linking, and cell cycle perturbations induced by nitrogen mustard.

O'Connor PM, Ferris DK, White GA, Pines J, Hunter T, Longo DL, Kohn KW.

Cell Growth Differ. 1992 Jan;3(1):43-52.

36.

tpr-met oncogene product induces maturation-producing factor activation in Xenopus oocytes.

Daar IO, White GA, Schuh SM, Ferris DK, Vande Woude GF.

Mol Cell Biol. 1991 Dec;11(12):5985-91.

37.
38.

p34cdc2 is physically associated with and phosphorylated by a cdc2-specific tyrosine kinase.

Ferris DK, White GA, Kelvin DJ, Copeland TD, Li CC, Longo DL.

Cell Growth Differ. 1991 Jul;2(7):343-9.

39.

Nuclear and cytoplasmic location of the FER tyrosine kinase.

Hao QL, Ferris DK, White G, Heisterkamp N, Groffen J.

Mol Cell Biol. 1991 Feb;11(2):1180-3.

40.

Enhanced therapeutic efficacy against an ovarian tumor xenograft of immunotoxins used in conjunction with recombinant alpha-interferon.

Pearson JW, Hedrick E, Fogler WE, Bull RL, Ferris DK, Riggs CW, Wiltrout RH, Sivam G, Morgan AC, Groves E, et al.

Cancer Res. 1990 Oct 1;50(19):6379-88.

41.

Haemopoietic growth factor regulation of protein kinases and genes associated with cell proliferation.

Farrar WL, Ferris DK, Linnekin D.

Ciba Found Symp. 1990;148:127-37; discussion 137-44. Review.

PMID:
2180644
42.

Hematopoietic growth-factor signal transduction and regulation of gene expression.

Farrar WL, Brini AT, Harel-Bellan A, Korner M, Ferris DK.

Immunol Ser. 1990;49:379-410. Review.

PMID:
2090258
43.

Two-dimensional gels and amino acid hydrolysis data.

Farrar WL, Ferris DK.

J Immunol. 1989 Dec 1;143(11):3862-3. No abstract available.

PMID:
2584724
44.

Novel characteristics of a 33KDa protein (pp33) rapidly phosphorylated in IL3 dependent cells by stimulation with IL3.

Garland JM, Ferris DK, Farrar WL.

Biochem Biophys Res Commun. 1989 Oct 16;164(1):520-30.

PMID:
2803317
45.

IL-2 regulation of tyrosine kinase activity is mediated through the p70-75 beta-subunit of the IL-2 receptor.

Ferris DK, Willette-Brown J, Ortaldo JR, Farrar WL.

J Immunol. 1989 Aug 1;143(3):870-6.

PMID:
2787350
47.

In situ detection of a heat-shock regulatory element binding protein using a soluble synthetic enhancer sequence.

Harel-Bellan A, Brini AT, Ferris DK, Robin P, Farrar WL.

Nucleic Acids Res. 1989 Jun 12;17(11):4077-87.

48.

Interleukin 3 and phorbol ester stimulate tyrosine phosphorylation of overlapping substrate proteins.

Ferris DK, Willette-Brown J, Martensen T, Farrar WL.

FEBS Lett. 1989 Mar 27;246(1-2):153-8.

49.

Comparative analysis of IL-2 and IL-3 induced tyrosine phosphorylation.

Ferris DK, Willette-Brown J, Linnekin D, Farrar WL.

Lymphokine Res. 1989 Fall;8(3):215-24.

PMID:
2789316
50.

The molecular basis of immune cytokine action.

Farrar WL, Ferris DK, Harel-Bellan A.

Crit Rev Ther Drug Carrier Syst. 1989;5(4):229-61. Review.

PMID:
2653649

Supplemental Content

Loading ...
Support Center